|Videos|April 2, 2021
Variety of Stroke Data Presented at ISC 2021: Ralph Sacco, MD, MS, FAAN, FAHA
Author(s)Ralph Sacco, MD, MS, FAAN, FAHA
The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine detailed a number of presentations from ISC 2021.
Advertisement
"Cardiac monitoring occurs when you have a stroke, and the reason is because you want to look for atrial fibrillation, which is an abnormal heart rhythm that can increase the risk of stroke if it's left untreated. In our cryptogenic, or unexplained strokes, it’s been shown in other studies that the more you monitor, the more you find atrial fibrillation.”
A number of presentations presented at the American Stroke Association’s (ASA) International Stroke Conference 2021 , March 17-19, contained data from the Florida Stroke Registry. Among them included outcomes in intracerebral hemorrhage in patients presenting impaired level of consciousness, race-ethnic disparities in intracerebral hemorrhage outcomes, and trends in cardiac monitoring after ischemic stroke and transient ischemic attack.
Other abstracts touched up the disparities in timelines of hospital presentation in patients with ischemic stroke, association between antidepressants use and stroke subtypes, and disparities in delivery of endovascular therapy. Ralph Sacco, MD, MS, FAAN, FAHA, is the director of the Florida Stroke Registry, an initiative that began in 2017 as a National Institute of Health funded program focused on reducing health disparities in stroke treatment and improving healthcare outcomes.
Sacco also serves as the chair of neurology and the Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine. He recently sat down with NeurologyLive to highlight these research projects and provide greater detail on the significance of the findings.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Expanding the Alzheimer Drug Development Pipeline
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
5